Prevention of Disease in the Past Five Years

In the recent past there have been significant advances in the way treatment and prevention of from diabetes have been handled. There are generally three levels of disease prevention. The first is the primary level, this level focuses on measures to prevent a person from a disease and it includes, immunisation, having a healthy diet, exercising among other preventive measures. The second level involves early detection of the disease in an attempt stop it before it manifests further or with the aim of minimising the damage it can cause if not attended to in time. Some of these measures include, early screening, checking the blood pressure, pulse rate, body temperature and other physical factors. The third and final level is the tertiary level .This level focuses on treatment of the already manifested disease (Blais & Hayes, 2016). 

In the past, in matters concerning diabetes, nurses and health officials were more focused on the last two preventive levels. The health officials did not seem to care for patients until they were actually sick. They put up more resources on early screening of the disease since research had shown that if detected early, diabetes could be cured easily. Research also showed that, in the event that patients with prediabetes were not taken care of in time, diabetes would develop to as much as 37 % in just four years (Lily, 2009). In the past five years however, there have been a changed in the prevention of diabetes in which one of them includes promoting primary preventive means (Blais & Hayes, 2016). Nurses and insurance companies are now investing most of their resources on the preventive level of disease management. They are advocating for a healthy diet as well as educating people on the best practices for prevention against diseases. It also my opinion that the primary protective level be enforced more since it shields the patient from the pain of enduring diabetes. It is also economically feasible since it will cost both the insurance company and the patients less amount of money in preventing rather curing the disease. 

Reference

Lily M, G. M. (2009). Treating prediabetes with Metaformin. Systematic review and meta-analysis .